DOCUSIGN insider files Form 144 for 7,500-share sale via Morgan Stanley
Rhea-AI Filing Summary
DOCUSIGN, INC. (DOCU) filed a Form 144 notifying the proposed sale of 7,500 common shares, with an aggregate market value of $533,977.50, through Morgan Stanley Smith Barney LLC on or about 10/01/2025. The filing lists total shares outstanding as 201,104,117, indicating the sale represents a very small fraction of outstanding stock. All 7,500 shares were acquired as restricted stock from the issuer on four dates in 2023 and 2024, and no other sales by the reporting person were reported in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- Full compliance with Rule 144 disclosure elements including broker, acquisition history, and signature attestation
- Transparency about acquisition dates and that shares were issued as restricted stock
- Immaterial size of the proposed sale relative to 201,104,117 shares outstanding, suggesting limited market impact
Negative
- None.
Insights
TL;DR: Routine insider sale notice for 7,500 restricted shares; immaterial relative to outstanding shares.
The Form 144 documents an intended sale of 7,500 common shares valued at $533,977.50 to be executed via Morgan Stanley Smith Barney LLC around October 1, 2025. Acquisition history shows these shares originated as restricted stock grants from the issuer on four separate dates in 2023 and 2024, totaling the 7,500 shares offered. With 201,104,117 shares outstanding, the proposed sale represents roughly 0.0037% of the float, which is immaterial from a market-impact perspective. The filing contains the standard attestation regarding no undisclosed material adverse information.
TL;DR: Procedural compliance with Rule 144; disclosure aligns with insider sale reporting practices.
The filing appears to comply with Rule 144 disclosure requirements: it identifies the broker, the class and quantity of securities, acquisition dates and nature (restricted stock), and reports no sales in the prior three months. The seller’s attestation about material information and the inclusion of plan/adoption date fields (left blank) are consistent with routine insider sale notices. There is no indication in the filing of any special restrictions or irregularities that would raise governance concerns.